CVS Health Corp (CVS) Shares Sold by MAI Capital Management

MAI Capital Management cut its holdings in shares of CVS Health Corp (NYSE:CVS) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 92,924 shares of the pharmacy operator’s stock after selling 4,801 shares during the quarter. MAI Capital Management’s holdings in CVS Health were worth $6,737,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Pathstone Family Office LLC raised its stake in shares of CVS Health by 341.0% in the second quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock valued at $2,353,000 after purchasing an additional 982 shares in the last quarter. Wealthcare Advisory Partners LLC raised its stake in shares of CVS Health by 330.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 991 shares in the last quarter. Fieldpoint Private Securities LLC raised its stake in shares of CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,000 shares in the last quarter. Arcadia Investment Management Corp MI raised its stake in shares of CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after purchasing an additional 726 shares in the last quarter. Finally, MPS Loria Financial Planners LLC acquired a new position in shares of CVS Health in the second quarter valued at $119,000. Institutional investors own 83.11% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of CVS Health Corp (NYSE CVS) opened at $69.27 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.52 and a current ratio of 1.02. The company has a market capitalization of $69,353.41, a price-to-earnings ratio of 10.71, a PEG ratio of 1.13 and a beta of 1.03. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.00.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.71 earnings per share. research analysts expect that CVS Health Corp will post 6.37 EPS for the current fiscal year.

A number of research analysts recently commented on CVS shares. Raymond James Financial upgraded CVS Health from an “outperform” rating to a “strong-buy” rating and set a $90.00 target price for the company in a research note on Thursday, January 4th. They noted that the move was a valuation call. Citigroup set a $76.00 target price on CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Jefferies Group set a $76.00 target price on CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Leerink Swann set a $85.00 target price on CVS Health and gave the company a “buy” rating in a research note on Monday, December 4th. Finally, Needham & Company LLC upped their target price on CVS Health from $79.00 to $85.00 and gave the company a “buy” rating in a research note on Monday, December 4th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $87.03.

In other news, EVP Helena Foulkes sold 19,965 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the sale, the executive vice president now owns 65,072 shares in the company, valued at $4,622,714.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the sale, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “CVS Health Corp (CVS) Shares Sold by MAI Capital Management” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://sportsperspectives.com/2018/03/10/cvs-health-corp-cvs-shares-sold-by-mai-capital-management.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply